This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

March 18, 2021
Delivered DigitallyCentral European Time

Ciscovery Bio Inc

Profile

Ciscovery Bio is a Philadelphia-based, Rutgers University spinoff that was founded in 2019. We discover and commercialize a large number of gene regulatory DNA elements named CRMs in the non-coding genome for drug development and treatment. CRMs are collectively used as biomarkers to comprehensively detect cellular changes for drug screening and individually used to control the expression of a transgene for gene therapy. Through our service, drug discovery companies can eliminate unwanted candidates (i.e., toxic or low-efficacy drugs) with high accuracy, precision medicine companies can better predict personal variation in drug response, and gene therapy companies can achieve more targeted expression of transgenes to minimize off-target effects.